Results 211 to 220 of about 172,684 (356)

In Vivo T Cell Depletion With Dexamethasone Reduces Graft Versus Host Disease (GVHD) With Minimal Side Effects and No Additional Risk of Early Relapse After Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

, 2011
Raquel Innis‐Shelton, Khairil Ashraff, Y. Li, Nalini Mehta, Donna Salzman, Arabella B. Tilden, William P. Vaughan, Lawrence S. Lamb   +7 more
openalex   +1 more source

Graft‐versus‐host disease‐like erythroderma: a manifestation of thymoma‐associated multiorgan autoimmunity [PDF]

, 2015
Shay Warren, Kishwer S. Nehal, Christiane Querfeld, Richard J. Wong, James Huang, Melissa Pulitzer   +5 more
openalex   +1 more source

Current therapeutics for sclerotic and fibrotic manifestations of chronic graft-versus-host disease. [PDF]

Bone Marrow Transplant
Choe H, DeFilipp Z.
europepmc   +1 more source

Implantable Drug Delivery Systems for Skeletal Muscles and Eyes

Advanced NanoBiomed Research, EarlyView.
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov, Murugan Ramalingam, Hongkai Wu, Toshinori Fujie, Yukinari Nakamura, Takeshi Hori, Yuji Nashimoto, Xuetao Shi, Hirokazu Kaji   +8 more
wiley   +1 more source

Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.

, 1988
R Hard, M R Patel, LYNDA M. KELLER, T. Juhani Linna   +3 more
openalex   +1 more source

Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft‐versus‐host disease control [PDF]

, 2016
Ma Carmen Herrero‐Sánchez, Concepción Rodríguez‐Serrano, Júlia Almeida, Laura San‐Segundo, Susana Inogés, Ángel Santos‐Briz, Jesús G. Briñón, Jesús F. San Miguel, Consuelo del Cañizo, Belén Blanco   +9 more
openalex   +1 more source

"The microbiome in graft-versus-host disease: a tale of two ecosystems". [PDF]

J Transl Med
Soleimani Samarkhazan H, Nouri S, Maleknia M, Aghaei M.   +3 more
europepmc   +1 more source

Selective Promotion of Retinal Organoid Attachment and Differentiation by Amine‐ and Hydroxyl‐Modified Surfaces

Advanced NanoBiomed Research, EarlyView.
Engineered biomaterial interfaces critically control retinal organoid development. This study examines how surface modifications (amine, hydroxyl, phenyl, and methyl groups) dictate organoid response. Hydrophilic surfaces markedly increase migration and foster retinal ganglion cell differentiation.
Luis Marcos, Charlie Hall, Eric J. Hill, Samantha L. Wilson, Paul Roach   +4 more
wiley   +1 more source

Xenopax is effective for the treatment and prophylaxis of acute graft-versus-host disease. [PDF]

Blood Sci
Liu D.
europepmc   +1 more source

Engineering Tertiary Lymphoid Structures: Nanomedicine, Bioengineering, and Biomaterials for Precision Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review explains how biomaterials and nanoparticles can be used to induce or modulate tertiary lymphoid structures (TLSs), which are ectopic immune hubs that form in nonlymphoid tissues during chronic disease and cancer. By comparing different methods, the article highlights design principles for modeling TLSs or recapitulating specific TLS ...
Shaza Karaman, Mei ElGindi, Jeremy Teo
wiley   +1 more source